• Special ‘C. Kent Osborne Symposium’ to focus on HER2, ER crosstalk

    Special ‘C. Kent Osborne Symposium’ to focus on HER2, ER crosstalk

    In recognition of his pioneering work on the interplay between ER and HER2 signaling, Dr. Osborne will be the special guest at this symposium bearing his name. Speakers will explore what is known about the crosstalk between these signaling pathways, how it takes place, and the latest evidence on the most effective therapies for patients…

  • Clinical Controversies: Experts debate topics in breast cancer treatment, research

    Clinical Controversies: Experts debate topics in breast cancer treatment, research

    In the first of two new ‘Controversies’ sessions at SABCS 2022, Lisa Carey, MD, ScM, FASCO, will lead discussions by experts on three important topics in breast cancer clinical care.

  • Clinical Research Workshop will focus on drug development, adherence in clinical trials

    Clinical Research Workshop will focus on drug development, adherence in clinical trials

    Aditya Bardia, MD, MPH, will moderate this year’s Clinical Research Workshop. Among the presentations, Dawn L. Hershman, MD, MS, will discuss drug adherence in clinical trials.

  • Early-Bird discount ends soon — book your housing and register today!

    Early-Bird discount ends soon — book your housing and register today!

    SABCS offers attendees the option to participate in person in San Antonio or virtually from anywhere in the world. Special early-bird pricing is available for both in-person and virtual registrations until October 31.

  • Highlights from the Program Committee

    Highlights from the Program Committee

    SABCS Program Planning Committee members Sibylle Loibl, MD, PhD, and Fabrice André, MD, PhD, talk about what they are most looking forward to at SABCS 2022.

  • In person or virtual — network and connect at #SABCS22

    In person or virtual — network and connect at #SABCS22

    In addition to a cutting-edge scientific program, SABCS 2022 will offer attendees a variety of opportunities to engage, interact, and network with speakers, exhibitors, and one another.

  • SABCS 2022: Spotlight on Clinical Science

    SABCS 2022: Spotlight on Clinical Science

    From the latest clinical trial results to the newest therapies finding their way to the clinic, the SABCS 2022 scientific program showcases the most important and most impactful clinical advances in breast cancer treatment.

  • Highlights from the Program Committee — The Patient Perspective

    Highlights from the Program Committee — The Patient Perspective

    Patient advocate and SABCS Program Planning Committee member Thelma Brown, BSc, talks about what she’s looking forward to at SABCS 2022 and why you will not want to miss this year’s meeting.

  • Final call for late-breaking abstract submissions

    Final call for late-breaking abstract submissions

    Regular abstract submission has closed, but there is still time to submit late-breaking abstracts for consideration. The deadline to submit a late-breaking abstract is September 30.

  • Join us in San Antonio — register today!

    Join us in San Antonio — register today!

    While SABCS 2022 registration will once again feature a virtual option for those who can’t make it to San Antonio, there is no substitute for the in-person experience.